Go Pro
→ Read now. Do not delete. You’ve been warned. (From Porter & Company) (Ad)tc pixel Free CWEB Stock Alerts

Charlotte's Web (CWEB) Competitors

Charlotte's Web logo
C$0.44 +0.02 (+4.76%)
As of 07/7/2026 04:00 PM Eastern
Compare

CWEB vs. CPH, FIRE, ACB, EPI, and SUGR

Should you buy Charlotte's Web stock or one of its competitors? MarketBeat compares Charlotte's Web with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Charlotte's Web include Cipher Pharmaceuticals (CPH), Supreme Cannabis (FIRE), Aurora Cannabis (ACB), ESSA Pharma (EPI), and SugarBud Craft Growers (SUGR). These companies are all part of the "drug manufacturers - specialty & generic" industry.

How does Charlotte's Web compare to Cipher Pharmaceuticals?

Cipher Pharmaceuticals (TSE:CPH) and Charlotte's Web (TSE:CWEB) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their valuation, risk, earnings, profitability, analyst recommendations, institutional ownership, media sentiment and dividends.

Cipher Pharmaceuticals has a beta of 1.153706, meaning that its stock price is 15% more volatile than the broader market. Comparatively, Charlotte's Web has a beta of 1.013931, meaning that its stock price is 1% more volatile than the broader market.

2.3% of Cipher Pharmaceuticals shares are owned by institutional investors. Comparatively, 1.6% of Charlotte's Web shares are owned by institutional investors. 42.0% of Cipher Pharmaceuticals shares are owned by insiders. Comparatively, 11.3% of Charlotte's Web shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Cipher Pharmaceuticals currently has a consensus target price of C$17.00, suggesting a potential downside of 1.90%. Given Cipher Pharmaceuticals' stronger consensus rating and higher probable upside, equities research analysts clearly believe Cipher Pharmaceuticals is more favorable than Charlotte's Web.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cipher Pharmaceuticals
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Charlotte's Web
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

In the previous week, Cipher Pharmaceuticals' average media sentiment score of 0.00 equaled Charlotte's Web'saverage media sentiment score.

Company Overall Sentiment
Cipher Pharmaceuticals Neutral
Charlotte's Web Neutral

Cipher Pharmaceuticals has higher revenue and earnings than Charlotte's Web. Charlotte's Web is trading at a lower price-to-earnings ratio than Cipher Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cipher PharmaceuticalsC$50.94M8.64C$11.41MC$1.1914.56
Charlotte's WebC$48.79M2.44-C$25.55M-C$0.23N/A

Cipher Pharmaceuticals has a net margin of 60.82% compared to Charlotte's Web's net margin of -74.93%. Cipher Pharmaceuticals' return on equity of 25.69% beat Charlotte's Web's return on equity.

Company Net Margins Return on Equity Return on Assets
Cipher Pharmaceuticals60.82% 25.69% 7.90%
Charlotte's Web -74.93%-2,056.41%-17.25%

Summary

Cipher Pharmaceuticals beats Charlotte's Web on 13 of the 13 factors compared between the two stocks.

How does Charlotte's Web compare to Supreme Cannabis?

Supreme Cannabis (TSE:FIRE) and Charlotte's Web (TSE:CWEB) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, earnings, risk, media sentiment, institutional ownership, profitability, analyst recommendations and valuation.

Supreme Cannabis has higher revenue and earnings than Charlotte's Web. Charlotte's Web is trading at a lower price-to-earnings ratio than Supreme Cannabis, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Supreme CannabisC$53.29M0.00-C$23.65M-C$0.03N/A
Charlotte's WebC$48.79M2.44-C$25.55M-C$0.23N/A

In the previous week, Supreme Cannabis' average media sentiment score of 0.00 equaled Charlotte's Web'saverage media sentiment score.

Company Overall Sentiment
Supreme Cannabis Neutral
Charlotte's Web Neutral

Supreme Cannabis has a net margin of 0.00% compared to Charlotte's Web's net margin of -74.93%. Supreme Cannabis' return on equity of 0.00% beat Charlotte's Web's return on equity.

Company Net Margins Return on Equity Return on Assets
Supreme CannabisN/A N/A N/A
Charlotte's Web -74.93%-2,056.41%-17.25%

1.6% of Charlotte's Web shares are owned by institutional investors. 11.3% of Charlotte's Web shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

Supreme Cannabis beats Charlotte's Web on 6 of the 9 factors compared between the two stocks.

How does Charlotte's Web compare to Aurora Cannabis?

Aurora Cannabis (TSE:ACB) and Charlotte's Web (TSE:CWEB) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, earnings, risk, media sentiment, institutional ownership, profitability, analyst recommendations and valuation.

Aurora Cannabis has a beta of 0.268291, indicating that its stock price is 73% less volatile than the broader market. Comparatively, Charlotte's Web has a beta of 1.013931, indicating that its stock price is 1% more volatile than the broader market.

Charlotte's Web has lower revenue, but higher earnings than Aurora Cannabis. Charlotte's Web is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aurora CannabisC$320.59M0.73-C$44.16M-C$2.14N/A
Charlotte's WebC$48.79M2.44-C$25.55M-C$0.23N/A

Aurora Cannabis has a net margin of -12.13% compared to Charlotte's Web's net margin of -74.93%. Aurora Cannabis' return on equity of -7.25% beat Charlotte's Web's return on equity.

Company Net Margins Return on Equity Return on Assets
Aurora Cannabis-12.13% -7.25% -1.87%
Charlotte's Web -74.93%-2,056.41%-17.25%

4.1% of Aurora Cannabis shares are owned by institutional investors. Comparatively, 1.6% of Charlotte's Web shares are owned by institutional investors. 11.3% of Charlotte's Web shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Aurora Cannabis presently has a consensus target price of C$7.17, indicating a potential upside of 89.09%. Given Aurora Cannabis' stronger consensus rating and higher probable upside, equities analysts plainly believe Aurora Cannabis is more favorable than Charlotte's Web.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aurora Cannabis
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
Charlotte's Web
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

In the previous week, Charlotte's Web's average media sentiment score of 0.00 beat Aurora Cannabis' score of -1.00 indicating that Charlotte's Web is being referred to more favorably in the news media.

Company Overall Sentiment
Aurora Cannabis Negative
Charlotte's Web Neutral

Summary

Aurora Cannabis beats Charlotte's Web on 9 of the 15 factors compared between the two stocks.

How does Charlotte's Web compare to ESSA Pharma?

ESSA Pharma (CVE:EPI) and Charlotte's Web (TSE:CWEB) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, valuation, analyst recommendations, institutional ownership, dividends, profitability, earnings and risk.

1.6% of Charlotte's Web shares are owned by institutional investors. 11.3% of Charlotte's Web shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, ESSA Pharma's average media sentiment score of 0.00 equaled Charlotte's Web'saverage media sentiment score.

Company Overall Sentiment
ESSA Pharma Neutral
Charlotte's Web Neutral

ESSA Pharma has higher earnings, but lower revenue than Charlotte's Web. ESSA Pharma is trading at a lower price-to-earnings ratio than Charlotte's Web, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ESSA PharmaN/AN/AN/A-C$0.99N/A
Charlotte's WebC$48.79M2.44-C$25.55M-C$0.23N/A

ESSA Pharma has a net margin of 0.00% compared to Charlotte's Web's net margin of -74.93%. ESSA Pharma's return on equity of 0.00% beat Charlotte's Web's return on equity.

Company Net Margins Return on Equity Return on Assets
ESSA PharmaN/A N/A N/A
Charlotte's Web -74.93%-2,056.41%-17.25%

Summary

Charlotte's Web beats ESSA Pharma on 5 of the 8 factors compared between the two stocks.

How does Charlotte's Web compare to SugarBud Craft Growers?

SugarBud Craft Growers (CVE:SUGR) and Charlotte's Web (TSE:CWEB) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, profitability, media sentiment, valuation, risk and earnings.

In the previous week, SugarBud Craft Growers' average media sentiment score of 0.00 equaled Charlotte's Web'saverage media sentiment score.

Company Overall Sentiment
SugarBud Craft Growers Neutral
Charlotte's Web Neutral

SugarBud Craft Growers has a net margin of 2.11% compared to Charlotte's Web's net margin of -74.93%. SugarBud Craft Growers' return on equity of 10.07% beat Charlotte's Web's return on equity.

Company Net Margins Return on Equity Return on Assets
SugarBud Craft Growers2.11% 10.07% 5.13%
Charlotte's Web -74.93%-2,056.41%-17.25%

0.4% of SugarBud Craft Growers shares are held by institutional investors. Comparatively, 1.6% of Charlotte's Web shares are held by institutional investors. 30.2% of SugarBud Craft Growers shares are held by insiders. Comparatively, 11.3% of Charlotte's Web shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

SugarBud Craft Growers has higher revenue and earnings than Charlotte's Web. Charlotte's Web is trading at a lower price-to-earnings ratio than SugarBud Craft Growers, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SugarBud Craft GrowersC$662.89M0.37C$12.12MC$1.407.32
Charlotte's WebC$48.79M2.44-C$25.55M-C$0.23N/A

SugarBud Craft Growers has a beta of 2.768948, suggesting that its stock price is 177% more volatile than the broader market. Comparatively, Charlotte's Web has a beta of 1.013931, suggesting that its stock price is 1% more volatile than the broader market.

Summary

SugarBud Craft Growers beats Charlotte's Web on 9 of the 11 factors compared between the two stocks.

Get Charlotte's Web News Delivered to You Automatically

Sign up to receive the latest news and ratings for CWEB and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CWEB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CWEB vs. The Competition

Export
MetricCharlotte's WebDrug Manufacturers IndustryMedical SectorTSE Exchange
Market CapC$119.04MC$6.67BC$7.09BC$13.09B
Dividend YieldN/A2.83%2.67%6.17%
P/E Ratio-1.915.1127.1436.24
Price / Sales2.441,653.40582.3810.00
Price / Cash8.9010.1849.3482.29
Price / Book-4.6710.8010.734.44
Net Income-C$25.55MC$20.27BC$3.56BC$299.09M
7 Day PerformanceN/A0.83%1.51%0.46%
1 Month Performance-22.81%-0.62%6.44%0.41%
1 Year Performance214.29%8.81%33.16%33.82%

Charlotte's Web Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CWEB
Charlotte's Web
N/AC$0.44
+4.8%		N/A+266.7%C$119.04MC$48.79MN/A164
CPH
Cipher Pharmaceuticals
N/AC$16.87
+1.2%		C$17.00
+0.8%		+30.4%C$428.35MC$50.94M14.185
FIRE
Supreme Cannabis
N/AN/AN/AN/AC$259.40MC$53.29MN/A400
ACB
Aurora Cannabis
2.1057 of 5 stars		C$4.05
+2.5%		C$7.17
+77.0%		-37.4%C$250.87MC$320.59MN/A1,073
EPI
ESSA Pharma
N/AC$8.20
+7.2%		N/A+0.0%C$237.87MN/AN/A25

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (TSE:CWEB) was last updated on 7/8/2026 by MarketBeat.com Staff.
From Our Partners
Ray Dalio: Buy Gold. Get Paid.
Ray Dalio, founder of Bridgewater Associates, is urging investors to hold 15% of their portfolio in gold and c...
Investors Alley | Sponsoredtc pixel
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics | Sponsoredtc pixel
The Starlink of Energy
A portable energy unit - already used by the U.S. Navy for decades - is now drawing serious attention from Big...
Monument Traders Alliance | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Three companies about to leapfrog Nvidia [And transform the entire industry]
Tech forecaster George Gilder - who identified Amazon when it was still just an online bookstore and predicted...
Eagle Publishing | Sponsoredtc pixel
They proved it worked in '76. Then buried it.
In 1976, Chevron tapped an energy source with no fuel costs, no carbon, and no supply chain - then killed the ...
Behind the Markets | Sponsoredtc pixel
Elon Is Quietly Doubling Down on This Bizarre Asset
Yahoo Finance reports this technology 'May Unlock $400 Trillion' - and Bloomberg calls it 'unavoidable.' Elon ...
Brownstone Research | Sponsoredtc pixel